EP3066128
COMBINATION OF ANTI-KIR AND ANTI-CS1 ANTIBODIES TO TREAT MULTIPLE MYELOMA
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
5.11.2014EP published:
31.10.2018EP application number:
14803287.3
EPO information:
European Patent Register
Max expiry date:
4.11.2034
Title:
COMBINATION OF ANTI-KIR AND ANTI-CS1 ANTIBODIES TO TREAT MULTIPLE MYELOMA
Timeline
Today
5.11.2014EP application
31.10.2018EP Publication
Owner
Name:
Bristol-Myers Squibb CompanyAddress:
Route 206 and Province Line Road, 08543, Princeton, NJ, US
Name:
Innate PharmaAddress:
117, Avenue de Luminy, 13009, Marseille, FR
Inventor
Name:
ANDRE, PascaleAddress:
Marseille, FR
Name:
BLERY, MathieuAddress:
Marseille, FR
Name:
BONNAFOUS, CecileAddress:
Marseille, FR
Name:
GUPTA, Ashok, K.Address:
Princeton, NJ, US
Name:
SALTER-CID, Luisa, M.Address:
Princeton, NJ, US
Name:
ROBBINS, Michael DarronAddress:
Princeton, NJ, US
Priority
Number:
201361900775 PDate:
6.11.2013Country:
US
Classification
Categories:
C07K 16/28, A61K 39/395, A61P 35/00